Joel Greenblatt Gotham Asset Management
Joel Greenblatt is a co-founder of Gotham Asset Management and a well-known value investor, professor, and author. He gained wide recognition for The Little Book That Beats the Market and for popularizing a systematic value approach often called the “magic formula.” Greenblatt’s career spans special-situation investing, quantitative value strategies, and investor education.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BILL Holdings
BILL
|
+$41.5M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$35.9M |
| 3 |
Gotham Enhanced 500 ETF
GSPY
|
+$35.8M |
| 4 |
PayPal
PYPL
|
+$17.4M |
| 5 |
NATI
National Instruments Corp
NATI
|
+$12.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$14M |
| 2 |
Lam Research
LRCX
|
+$12.7M |
| 3 |
Meta Platforms (Facebook)
META
|
+$9.54M |
| 4 |
VMW
VMware, Inc
VMW
|
+$9.3M |
| 5 |
Valvoline
VVV
|
+$9.03M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.4% |
| 2 | Industrials | 12.68% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Healthcare | 8.73% |
| 5 | Financials | 6.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Lemonade
LMND
$4.13B
| $233K | ﹤0.01% |
14,455
-4,499
| -24% | -$67.8K |
|
|
LPRO
1202
DELISTED
Open Lending Corp
LPRO
| $233K | ﹤0.01% |
27,376
-17,567
| -39% | -$118K |
|
1203
STAG Industrial
STAG
$7.07B
| $233K | ﹤0.01% |
5,930
-33,176
| -85% | -$1.18M |
|
1204
JB Hunt Transport Services
JBHT
$25.9B
| $233K | ﹤0.01% |
1,165
-6
| -0.5% | -$1.11K |
|
1205
Synchrony
SYF
$25.9B
| $231K | ﹤0.01% |
6,050
-14,816
| -71% | -$469K |
|
1206
Terreno Realty
TRNO
$7.43B
| $230K | ﹤0.01% |
+3,676
| New | +$209K |
|
1207
Pediatrix Medical
MD
$2.16B
| $230K | ﹤0.01% |
24,757
-8,539
| -26% | -$88.3K |
|
1208
Resideo Technologies
REZI
$3.08B
| $229K | ﹤0.01% |
12,151
-626
| -5% | -$10.2K |
|
1209
Northern Trust
NTRS
$33.6B
| $229K | ﹤0.01% |
+2,708
| New | +$200K |
|
1210
Verra Mobility
VRRM
$693M
| $228K | ﹤0.01% |
+9,880
| New | +$203K |
|
1211
Dana Inc
DAN
$3.41B
| $227K | ﹤0.01% |
15,545
-7,603
| -33% | -$101K |
|
|
OLPX
1212
DELISTED
Olaplex Holdings
OLPX
| $226K | ﹤0.01% |
89,113
+9,295
| +12% | +$18.4K |
|
1213
Upstart Holdings
UPST
$2.95B
| $226K | ﹤0.01% |
+5,525
| New | +$168K |
|
1214
Beyond Meat
BYND
$254M
| $225K | ﹤0.01% |
844
-195
| -19% | -$46K |
|
1215
ABM Industries
ABM
$2.74B
| $225K | ﹤0.01% |
+5,016
| New | +$212K |
|
1216
CleanSpark
CLSK
$3.08B
| $224K | ﹤0.01% |
20,334
+9,197
| +83% | +$57.3K |
|
1217
Corteva
CTVA
$54.6B
| $224K | ﹤0.01% |
+4,668
| New | +$223K |
|
1218
Allegion
ALLE
$13.8B
| $223K | ﹤0.01% |
1,762
-2,258
| -56% | -$241K |
|
|
DMC
1219
Del Monte Corp
DMC
$1.48B
| $223K | ﹤0.01% |
8,488
-1,569
| -16% | -$38.6K |
|
1220
Belden
BDC
$4.79B
| $222K | ﹤0.01% |
+2,873
| New | +$213K |
|
1221
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $222K | ﹤0.01% |
2,541
-983
| -28% | -$71.2K |
|
1222
International Bancshares
IBOC
$4.45B
| $221K | ﹤0.01% |
+4,068
| New | +$189K |
|
|
MZTI
1223
The Marzetti Company
MZTI
$3.06B
| $221K | ﹤0.01% |
1,327
-6,883
| -84% | -$1.16M |
|
1224
East-West Bancorp
EWBC
$17.8B
| $220K | ﹤0.01% |
+3,062
| New | +$184K |
|
1225
Air Products & Chemicals
APD
$67.9B
| $220K | ﹤0.01% |
+802
| New | +$220K |
|
Similar funds
Joel Greenblatt's Q4 2023 Portfolio in Review
As of Q4 2023, Joel Greenblatt held 1,470 positions worth $5.39B, up 11% from $4.84B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Joel Greenblatt's Q4 2023 filing shows 157 new, 492 increased, 650 reduced and 145 closed positions. Its largest new stake was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M. The largest sale was Pfizer, an estimated $14M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Consumer Discretionary.
- Joel Greenblatt's largest Q4 2023 buy was Fidelity Fundamental Small-Mid Cap ETF: 457,078 shares worth $4.99M.
- Joel Greenblatt added most to BILL Holdings in Q4 2023, an estimated $41.5M increase.
- Joel Greenblatt's biggest Q4 2023 reduction was Pfizer, cutting an estimated $14M.
- Joel Greenblatt fully exited VMware, Inc in Q4 2023, selling an estimated $9.3M.
- Joel Greenblatt's ten largest holdings make up 24% of its $5.39B portfolio in Q4 2023.
- Joel Greenblatt opened 157 new positions and closed 145 in Q4 2023.
- Joel Greenblatt's portfolio value rose 11% quarter-over-quarter to $5.39B.
Based on Gotham Asset Management's 13F filing for Q4 2023, filed 14 Feb 2024.